These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17637721)

  • 1. Monoclonal T-cell receptors: new reagents for cancer therapy.
    Stauss HJ; Cesco-Gaspere M; Thomas S; Hart DP; Xue SA; Holler A; Wright G; Perro M; Little AM; Pospori C; King J; Morris EC
    Mol Ther; 2007 Oct; 15(10):1744-50. PubMed ID: 17637721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular immunology lessons from therapeutic T-cell receptor gene transfer.
    Thomas S; Stauss HJ; Morris EC
    Immunology; 2010 Feb; 129(2):170-7. PubMed ID: 20561357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic engineering with T cell receptors.
    Zhang L; Morgan RA
    Adv Drug Deliv Rev; 2012 Jun; 64(8):756-62. PubMed ID: 22178904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting T cell receptor genes for cancer immunotherapy.
    Xue S; Gillmore R; Downs A; Tsallios A; Holler A; Gao L; Wong V; Morris E; Stauss HJ
    Clin Exp Immunol; 2005 Feb; 139(2):167-72. PubMed ID: 15654813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
    Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
    Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells.
    Stauss HJ; Thomas S; Cesco-Gaspere M; Hart DP; Xue SA; Holler A; King J; Wright G; Perro M; Pospori C; Morris E
    Blood Cells Mol Dis; 2008; 40(1):113-6. PubMed ID: 17855129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic engineering of T cell specificity for immunotherapy of cancer.
    Willemsen RA; Debets R; Chames P; Bolhuis RL
    Hum Immunol; 2003 Jan; 64(1):56-68. PubMed ID: 12507815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor gene therapy of established tumors in a murine melanoma model.
    Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA
    J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell engineering for cancer immunotherapy.
    Sadelain M
    Cancer J; 2009; 15(6):451-5. PubMed ID: 20010162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-cistronic vector encoding optimized safety switch for adoptive therapy with T-cell receptor-modified T cells.
    van Loenen MM; de Boer R; Hagedoorn RS; Jankipersadsing V; Amir AL; Falkenburg JH; Heemskerk MH
    Gene Ther; 2013 Aug; 20(8):861-7. PubMed ID: 23364317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell receptor gene-modified cells: past promises, present methodologies and future challenges.
    Tendeiro Rego R; Morris EC; Lowdell MW
    Cytotherapy; 2019 Mar; 21(3):341-357. PubMed ID: 30655164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord blood T cells retain early differentiation phenotype suitable for immunotherapy after TCR gene transfer to confer EBV specificity.
    Frumento G; Zheng Y; Aubert G; Raeiszadeh M; Lansdorp PM; Moss P; Lee SP; Chen FE
    Am J Transplant; 2013 Jan; 13(1):45-55. PubMed ID: 23016879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR.
    Circosta P; Granziero L; Follenzi A; Vigna E; Stella S; Vallario A; Elia AR; Gammaitoni L; Vitaggio K; Orso F; Geuna M; Sangiolo D; Todorovic M; Giachino C; Cignetti A
    Hum Gene Ther; 2009 Dec; 20(12):1576-88. PubMed ID: 19678763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.
    Puig-Saus C; Parisi G; Garcia-Diaz A; Krystofinski PE; Sandoval S; Zhang R; Champhekar AS; McCabe J; Cheung-Lau GC; Truong NA; Vega-Crespo A; Komenan MDS; Pang J; Macabali MH; Saco JD; Goodwin JL; Bolon B; Seet CS; Montel-Hagen A; Crooks GM; Hollis RP; Campo-Fernandez B; Bischof D; Cornetta K; Gschweng EH; Adelson C; Nguyen A; Yang L; Witte ON; Baltimore D; Comin-Anduix B; Kohn DB; Wang X; Cabrera P; Kaplan-Lefko PJ; Berent-Maoz B; Ribas A
    Clin Cancer Res; 2019 Feb; 25(3):1000-1011. PubMed ID: 30409823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells.
    Berry LJ; Moeller M; Darcy PK
    Tissue Antigens; 2009 Oct; 74(4):277-89. PubMed ID: 19775368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid re-expression of retrovirally introduced versus endogenous TCRs in engineered T cells after antigen-specific stimulation.
    van Loenen MM; Hagedoorn RS; de Boer R; van Egmond EH; Falkenburg JH; Heemskerk MH
    J Immunother; 2011 Mar; 34(2):165-74. PubMed ID: 21304404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human.
    Sun Q; Zhang X; Wang L; Gao X; Xiong Y; Liu L; Wei F; Yang L; Ren X
    Cell Death Dis; 2019 Jun; 10(7):475. PubMed ID: 31209257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing TCR for cancer immunotherapy.
    Voss RH; Kuball J; Theobald M
    Methods Mol Med; 2005; 109():229-56. PubMed ID: 15585925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer.
    Perro M; Tsang J; Xue SA; Escors D; Cesco-Gaspere M; Pospori C; Gao L; Hart D; Collins M; Stauss H; Morris EC
    Gene Ther; 2010 Jun; 17(6):721-32. PubMed ID: 20164855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.